Patents by Inventor Jean-Leon Tchelingerian

Jean-Leon Tchelingerian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CELL COMPOSITION COMPRISING LIVER PROGENITOR CELLS EXPRESSING HLA-E
    Publication number: 20220049225
    Abstract: The current invention concerns isolated liver progenitor cells, cell lines thereof, cell populations comprising such and compositions comprising such wherein the liver progenitor cells are HLA-E positive. In addition, the invention concerns methods of preparing these liver progenitor cells.
    Type: Application
    Filed: December 12, 2019
    Publication date: February 17, 2022
    Inventors: Jean-Leon TCHELINGERIAN, Elisa CORRITORE, Giuseppe MAZZA, Nathalie BELMONTE, Etienne SOKAL
  • Insulin conjugates and methods of use thereof
    Patent number: 7112562
    Abstract: The invention relates generally to chimeric peptides and compositions that facilitate the transport of insulin across biological membranes, methods for preparing the chimeric peptides, and a method for treating a subject suffering from diabetes.
    Type: Grant
    Filed: January 9, 2006
    Date of Patent: September 26, 2006
    Assignee: Diatos, S.A.
    Inventor: Jean-Leon Tchelingerian
  • INSULIN CONJUGATES AND METHODS OF USE THEREOF
    Publication number: 20060166889
    Abstract: The invention relates generally to chimeric peptides and compositions that facilitate the transport of insulin across biological membranes, methods for preparing the chimeric peptides, and a method for treating a subject suffering from diabetes.
    Type: Application
    Filed: January 9, 2006
    Publication date: July 27, 2006
    Inventor: Jean-Leon Tchelingerian
  • Insulin conjugates and methods of use thereof
    Patent number: 7049286
    Abstract: The invention relates generally to chimeric peptides and compositions that facilitate the transport of insulin across biological membranes, methods for preparing the chimeric peptides, and a method for treating a subject suffering from diabetes.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: May 23, 2006
    Assignee: Diatos, S.A.
    Inventor: Jean-Leon Tchelingerian
  • Immortalized lines of endothelial brain cells and therapeutic applications thereof
    Publication number: 20040018619
    Abstract: The invention relates to optionally modified immortalized lines of endothelial brain cells of mammalians, as well as applications as preventive or curative drug and particularly for the treatment of primary and secondary, neurologic or psychiatric diseases, including brain tumor, and for stimulating the growth and reproduction of breeding animals. The invention also relates to the method for preparing said cell lines.
    Type: Application
    Filed: May 19, 2003
    Publication date: January 29, 2004
    Inventors: Nathalie Chaverot, Pierre-Olivier Couraud, John J. Laterra, Jerome Quinonero, Francoise Roux, Arthur Donny Strosberg, Jean-Leon Tchelingerian, Lionel Vignais
  • Insulin conjugates and methods of use thereof
    Publication number: 20030153490
    Abstract: The invention relates generally to chimeric peptides and compositions that facilitate the transport of insulin across biological membranes, methods for preparing the chimeric peptides, and a method for treating a subject suffering from diabetes.
    Type: Application
    Filed: August 29, 2002
    Publication date: August 14, 2003
    Inventor: Jean-Leon Tchelingerian